Foster Corporation and Drake Medical Plastics are working to provide a one-stop shop for precision polymer shapes and parts
May 13, 2021
PUTNAM, Conn.—Foster Corporation and Drake Medical Plastics, Ltd., recently entered into an exclusive sales agreement intended to streamline the companies’ services to customers in the global medical device marketplace. The agreement began April 1, 2021, creating “a one-stop shop for high performance polymers” that can be machined into precision shapes and components, according to a release from Foster Corporation.
Foster Corporation (www.fosterpolymers.com) produces polymer compounds for medical devices. Drake Medical Plastics, based in Cypress, Texas, converts high-performance polymers into stock shapes and precision parts. Drake provides “resin-to-shape” extrusion of medical-grade polymers into rod, plate, and tube for machined medical and life sciences components. The company also machines and injection molds precision parts.
Stock shapes are said to provide customers with a quick and economical route for prototypes and scaling up to commercial manufacturing. Depending on volume, machined parts can be a flexible platform for production parts with little to no capital investment, the companies said in the release.
Foster said that it currently provides highly engineered materials and compounds to be used in specialty medical and life sciences applications. Its collaboration with Drake Medical Plastics will make medical compounds—including highly filled materials—available in machinable shapes made from Foster’s full range of polymer compounds.
“We are very excited to be working with Foster, a world class company that shares our passion for customer success,” said Steve Quance, president of Drake Medical Plastics, in the release. “This agreement will streamline customers’ access to the medical polymer component solutions they require.”
Foster Corporation’s biomedical materials include custom medical compounds, implantable materials, and drug/polymer blends. The firm’s facilities are ISO 13485:2003 and ISO 9001:2008 certified.
“We are extremely happy to enter into this exclusive sales agreement with Drake Medical Plastics,” said Larry Johnson, vice president of business development at Foster Corporation, in the release. “Our focus on problem-solving with highly engineered polymer solutions in the medical market segment is in direct alignment with Drake’s strategy. Both of our companies focus heavily on great customer service and meeting critical customer expectations.”
Drake Medical Plastics (www.drakemedicalplastics.com) operates an ISO 13485:2016 certified device manufacturing facility and is a U.S. FDA registered device contract manufacturer.